1. AB0051 Monocytes from Patients with Rheumatoid Arthritis and Type 2 Diabetes Mellitus Display an Increased Production of IL-1β Via the NLRP3-Inflammasome Activation. A Possible Implication for Therapeutic Decision in These Patients. (9th June 2015) Authors: Ruscitti, P.; Di Benedetto, P.; Cipriani, P.; Liakouli, V.; Berardicurti, O.; Carubbi, F.; Alvaro, S.; Giacomelli, R. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0226 Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC). (23rd January 2014) Authors: Cipriani, P.; Marrelli, A.; Di Benedetto, P.; Liakouli, V.; Carubbi, F.; Ruscitti, P.; Pantano, I.; Alvaro, S.; Giacomelli, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0244 Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). (23rd January 2014) Authors: Cipriani, P.; Di Benedetto, P.; Marrelli, A.; Liakouli, V.; Carubbi, F.; Ruscitti, P.; Alvaro, S.; Pantano, I.; Giacomelli, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0248 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis. (23rd January 2014) Authors: Cipriani, P.; Liakouli, V.; Marrelli, A.; Di Benedetto, P.; Carubbi, F.; Ruscitti, P.; Alvaro, S.; Pantano, I.; Giacomelli, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)‐1β via the nucleotide‐binding domain and leucine‐rich repeat containing family pyrin 3(NLRP3)‐inflammasome activation: a possible implication for therapeutic decision in these patients. (19th July 2015) Authors: Ruscitti, P.; Cipriani, P.; Di Benedetto, P.; Liakouli, V.; Berardicurti, O.; Carubbi, F.; Ciccia, F.; Alvaro, S.; Triolo, G.; Giacomelli, R. Journal: Clinical and experimental immunology Issue: Volume 182:Number 1(2015:Oct.) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0191 Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren's syndrome. (23rd January 2014) Authors: Cipriani, P.; Carubbi, F.; Marrelli, A.; Di Benedetto, P.; Liakouli, V.; Ruscitti, P.; Pantano, I.; Alvaro, S.; Giacomelli, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0148 EFFICACY OF IL-1 INHIBITION ON RHEUMATOID ARTHRITIS AND TYPE 2 DIABETES, LONG-TERM FINDINGS FROM TRACK STUDY, A MULTICENTRE, OPEN-LABEL, RANDOMISED CONTROLLED TRIAL. (2nd June 2020) Authors: Ruscitti, P.; Alvaro, S.; Liakouli, V.; Sensini, F.; Cipriani, P.; Giacomelli, R. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗